Alexander Spektor, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiation Oncology | 6 | 2019 | 555 | 0.550 |
Why?
|
Palliative Care | 9 | 2022 | 3493 | 0.530 |
Why?
|
Chromosomes | 1 | 2017 | 596 | 0.490 |
Why?
|
Genomic Instability | 2 | 2017 | 695 | 0.480 |
Why?
|
Microtubule-Associated Proteins | 3 | 2009 | 1086 | 0.320 |
Why?
|
Chromosome Breakage | 2 | 2020 | 173 | 0.300 |
Why?
|
Neoplasms | 11 | 2022 | 21683 | 0.290 |
Why?
|
Clinical Clerkship | 3 | 2015 | 532 | 0.250 |
Why?
|
Centrioles | 3 | 2009 | 79 | 0.240 |
Why?
|
DNA Damage | 3 | 2020 | 2432 | 0.230 |
Why?
|
Cilia | 1 | 2007 | 466 | 0.230 |
Why?
|
Tattooing | 1 | 2023 | 58 | 0.230 |
Why?
|
Radiosurgery | 2 | 2023 | 1329 | 0.230 |
Why?
|
Phosphoproteins | 3 | 2020 | 2440 | 0.200 |
Why?
|
Cell Cycle Proteins | 2 | 2009 | 3462 | 0.170 |
Why?
|
Bone Diseases | 1 | 2022 | 416 | 0.160 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2018 | 97 | 0.160 |
Why?
|
Azepines | 1 | 2019 | 336 | 0.150 |
Why?
|
Neoplasm Metastasis | 4 | 2021 | 4851 | 0.140 |
Why?
|
Lymphopenia | 1 | 2018 | 285 | 0.140 |
Why?
|
Bone Neoplasms | 2 | 2019 | 2529 | 0.140 |
Why?
|
Nucleotidyltransferases | 1 | 2017 | 220 | 0.130 |
Why?
|
Micronuclei, Chromosome-Defective | 1 | 2015 | 38 | 0.130 |
Why?
|
Mitosis | 1 | 2020 | 1208 | 0.120 |
Why?
|
Radiotherapy | 2 | 2018 | 1533 | 0.120 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2018 | 388 | 0.120 |
Why?
|
Genes, Tumor Suppressor | 1 | 2018 | 1097 | 0.120 |
Why?
|
Immune System | 1 | 2019 | 805 | 0.120 |
Why?
|
Curriculum | 3 | 2015 | 3605 | 0.110 |
Why?
|
Brain Neoplasms | 3 | 2019 | 8863 | 0.110 |
Why?
|
Combined Modality Therapy | 3 | 2021 | 8642 | 0.110 |
Why?
|
Life Expectancy | 1 | 2019 | 1184 | 0.110 |
Why?
|
Spinal Neoplasms | 1 | 2019 | 760 | 0.100 |
Why?
|
Indoles | 1 | 2019 | 1839 | 0.100 |
Why?
|
Pain | 3 | 2022 | 4986 | 0.100 |
Why?
|
Pain Measurement | 1 | 2020 | 3420 | 0.090 |
Why?
|
Tumor Microenvironment | 2 | 2019 | 3586 | 0.090 |
Why?
|
Lung Neoplasms | 3 | 2020 | 13102 | 0.090 |
Why?
|
Melanoma | 2 | 2019 | 5510 | 0.090 |
Why?
|
Program Evaluation | 2 | 2015 | 2488 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2019 | 2915 | 0.090 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2018 | 1861 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2019 | 5172 | 0.080 |
Why?
|
Career Choice | 1 | 2014 | 744 | 0.080 |
Why?
|
Polyploidy | 1 | 2007 | 114 | 0.070 |
Why?
|
Precipitin Tests | 1 | 2007 | 829 | 0.070 |
Why?
|
Education, Medical, Undergraduate | 1 | 2015 | 1008 | 0.070 |
Why?
|
Centrosome | 1 | 2007 | 201 | 0.070 |
Why?
|
Cytokinesis | 1 | 2007 | 177 | 0.070 |
Why?
|
Chromosome Segregation | 2 | 2018 | 235 | 0.070 |
Why?
|
NIH 3T3 Cells | 1 | 2007 | 677 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2017 | 2958 | 0.070 |
Why?
|
Students, Medical | 2 | 2015 | 1862 | 0.060 |
Why?
|
Cell Cycle | 2 | 2009 | 2967 | 0.060 |
Why?
|
Cell Line, Tumor | 4 | 2020 | 16689 | 0.060 |
Why?
|
Humans | 25 | 2023 | 744343 | 0.060 |
Why?
|
DNA | 1 | 2017 | 7301 | 0.060 |
Why?
|
Mutation | 4 | 2020 | 29786 | 0.060 |
Why?
|
Cell Line | 4 | 2015 | 15997 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2018 | 10481 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 2 | 2009 | 3772 | 0.050 |
Why?
|
Green Fluorescent Proteins | 1 | 2007 | 2088 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 1 | 2017 | 3143 | 0.050 |
Why?
|
Cell Division | 1 | 2009 | 4568 | 0.050 |
Why?
|
Quality of Life | 2 | 2020 | 12804 | 0.050 |
Why?
|
S Phase | 2 | 2015 | 423 | 0.050 |
Why?
|
Immunotherapy | 1 | 2017 | 4445 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2019 | 3557 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6773 | 0.050 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 2 | 2023 | 1624 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2019 | 5686 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11524 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2017 | 4262 | 0.050 |
Why?
|
raf Kinases | 1 | 2019 | 122 | 0.040 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2023 | 450 | 0.040 |
Why?
|
Actomyosin | 1 | 2020 | 111 | 0.040 |
Why?
|
Exodeoxyribonucleases | 1 | 2020 | 180 | 0.040 |
Why?
|
Workflow | 1 | 2023 | 847 | 0.040 |
Why?
|
Mechanical Phenomena | 1 | 2020 | 140 | 0.040 |
Why?
|
RNA Interference | 1 | 2007 | 2889 | 0.040 |
Why?
|
Health Facilities | 1 | 2023 | 573 | 0.040 |
Why?
|
Animals | 6 | 2019 | 168757 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 5221 | 0.040 |
Why?
|
Program Development | 2 | 2015 | 1316 | 0.040 |
Why?
|
RNA, Small Interfering | 1 | 2007 | 3505 | 0.040 |
Why?
|
Cultural Characteristics | 1 | 2019 | 262 | 0.040 |
Why?
|
Death | 1 | 2022 | 678 | 0.040 |
Why?
|
Single-Cell Analysis | 2 | 2020 | 2183 | 0.040 |
Why?
|
Referral and Consultation | 2 | 2020 | 3528 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2019 | 648 | 0.040 |
Why?
|
Internship and Residency | 1 | 2017 | 5788 | 0.040 |
Why?
|
Morals | 1 | 2019 | 284 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2018 | 793 | 0.030 |
Why?
|
Mutagenesis | 1 | 2020 | 1266 | 0.030 |
Why?
|
Interferon Type I | 1 | 2019 | 542 | 0.030 |
Why?
|
Gene Dosage | 1 | 2020 | 1252 | 0.030 |
Why?
|
Dermatitis | 1 | 2017 | 197 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2019 | 1655 | 0.030 |
Why?
|
Spirituality | 1 | 2019 | 405 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2022 | 77449 | 0.030 |
Why?
|
Cranial Irradiation | 1 | 2017 | 401 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1038 | 0.030 |
Why?
|
Aged | 7 | 2020 | 163280 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2019 | 921 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2020 | 57776 | 0.030 |
Why?
|
Chicago | 1 | 2014 | 240 | 0.030 |
Why?
|
Mice | 4 | 2019 | 81183 | 0.030 |
Why?
|
Male | 9 | 2022 | 350118 | 0.030 |
Why?
|
Middle Aged | 7 | 2020 | 213383 | 0.030 |
Why?
|
Mice, Nude | 1 | 2018 | 3689 | 0.030 |
Why?
|
Qualitative Research | 1 | 2020 | 2682 | 0.030 |
Why?
|
Kidney | 1 | 2007 | 7186 | 0.030 |
Why?
|
Female | 9 | 2020 | 380194 | 0.020 |
Why?
|
Models, Biological | 1 | 2007 | 9583 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2018 | 6314 | 0.020 |
Why?
|
Prospective Studies | 3 | 2020 | 53288 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2015 | 1179 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2017 | 2453 | 0.020 |
Why?
|
Advance Care Planning | 1 | 2017 | 662 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2727 | 0.020 |
Why?
|
G2 Phase | 1 | 2009 | 139 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 2014 | 1179 | 0.020 |
Why?
|
Colitis | 1 | 2017 | 1170 | 0.020 |
Why?
|
Educational Measurement | 1 | 2015 | 1210 | 0.020 |
Why?
|
Genome, Human | 1 | 2020 | 4420 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2015 | 1941 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2021 | 11031 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4479 | 0.020 |
Why?
|
Neutrophils | 1 | 2018 | 3719 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7785 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10397 | 0.020 |
Why?
|
Terminal Care | 1 | 2017 | 1694 | 0.020 |
Why?
|
Cell Survival | 1 | 2015 | 5882 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2022 | 63114 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2015 | 2759 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9438 | 0.020 |
Why?
|
Adult | 4 | 2020 | 214055 | 0.020 |
Why?
|
Massachusetts | 1 | 2017 | 8663 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2019 | 5535 | 0.010 |
Why?
|
Apoptosis | 1 | 2018 | 9727 | 0.010 |
Why?
|
Boston | 1 | 2014 | 9313 | 0.010 |
Why?
|
United States | 2 | 2017 | 69872 | 0.010 |
Why?
|
Clinical Competence | 1 | 2014 | 4687 | 0.010 |
Why?
|
Signal Transduction | 1 | 2018 | 23403 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13695 | 0.010 |
Why?
|